← Eichor
Study identifier: NCT03987334 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Virtual Reality Rehabilitation in Neck Pain Subjects

Condition: Neck Pain · Chronic Pain · Whiplash  ·  Sponsor: IRCCS San Raffaele

PhaseNA
Planned participants72
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

VR-NECKPAIN is a two-arm, monocentric, single-blind, randomized controlled trial in Neck Pain patients. The entire treatment consist in 12 sessions, each during 45 minutes, twice a week for 6 consecutive weeks. Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). There will also be a 3 months Follow-Up assessment (T2). The total duration of study participation for each subject will be approximately 19 weeks, including evaluation at T0, treatment and evaluation at T1 and T2. Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR subjects, in terms of intensity, time and type, but with the virtual reality turned off.

This description comes directly from the study's public registry record.

Talk to the study team

Sandro Iannaccone, Dr  ·  +39 0226435734  ·  iannaccone.sandro@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCSS Ospedale San RaffaeleMilan, MI, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03987334